Clinical Trials Browser

Terminated × Breast Neoplasms × Dexamethasone × Clear all

NCT05070247 2026-01-22

A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

BreastGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Mesothelioma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00253318 2025-04-27

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

Phase 1 Terminated

15 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01698281 2018-02-22

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

Phase 2 Terminated

7 enrolled

Breast

Breast Neoplasms

NCT00832338 2017-08-31

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Phase 2 Terminated

23 enrolled 8 charts

Breast

Breast Neoplasms

NCT00869973 2013-01-23

Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients

Phase 3 Terminated

580 enrolled

Breast

Breast Neoplasms, Vomiting

NCT00215748 2007-11-16

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Phase 2 Terminated

40 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms